Investing In The Future Of Cataract Surgery: The RxSight Advantage

52 Week Range 66.54 20.66 Day Range 52.42 51.03 ● eps (fwd) -0.82 PE . Div Rate . Yield Short Interest 5.02% Market Cap $2.07B Volume 172,598 Prev. Close $52.16 David Trood RtsSight, Inc. (NASDAQ:RXST) is a pioncering medical technology company dedicated to transforming the cataract surgery landscape. The company's flagship rectual online (10,000 (0.101) posted, is the first and only FDA-approved premium intraocular clargest, mocendar. margesty, anto compary, v mbosmper in viagampe vindeming m and unparalle ...